Tag: Immuno
Ose immuno: A European patent for CLEC-1
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
OSE Immuno: a European patent for CLEC-1
(CercleFinance.com) – OSE Immunotherapeutics announces that the European Patent Office (EPO) has granted a new patent which strengthens the protection of CLEC-1, its new myeloid checkpoint inhibitor target, and its…
OSE Immuno: a European patent for CLEC-1 – 05/02/2022 at 09:45
(CercleFinance.com) – OSE Immunotherapeutics announces that the European Patent Office (EPO) has granted a new patent which strengthens the protection of CLEC-1, its new myeloid checkpoint inhibitor target, and its…
Ose immuno: Agreement for a patent in the USA
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
OSE Immuno announces positive long-term memory response with CoVepiT
By Hector Chaunu Published on 03/16/2022 at 6:17 p.m. Photo credit © Reuters …
OSE Immuno: appointment of Alexandre Lebeaut as independent director
By Hector Chaunu Published on 02/18/2022 at 6:18 p.m. Photo credit © Reuters …
Ose immuno: FDA Fast Track Designation for VEL-101
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
OSE Immuno: up after the announcements
Through Claude Leguilloux Published on 02/01/2022 at 11:01 Photo credit © Reuters (Boursier.com) — OSE Immuno climbed 7.3% on Tuesday to 8.80 euros, as the group announced the acceptance of…
OSE Immuno: FDA green light for Veloxis Pharmaceuticals
(CercleFinance.com) – OSE Immunotherapeutics announces that the United States Food & Drug Administration (FDA) has accepted the Investigational New Drug (IND) application formulated by Veloxis Pharmaceuticals for a clinical trial…
OSE Immuno: under 10 euros
Through Hector Chaunu Published on 01/17/2022 at 11:00 a.m. This stock market news is for subscribers only Privileges Test our stock market advice for €1, without obligation I subscribe Already…
Ose immuno: Degroof Petercam maintains the purchase
Read also (CercleFinance.com) – Degroof Petercam renewed its buy recommendation on OSE Immuno on Monday, with a price target maintained at 15.5 euros, following the departure of CEO Alexis Peyroles…
OSE Immuno appoints a transitional CEO, no impact according to an analyst firm
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? To sell ? What course objective? Our experts engage…